[Proteinuria and nephrotic syndrome in penicillamine therapy. Reversibility of immunopathologic findings in animal experiments].
D000418:Albumins / Q000032:analysis; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000941:Antigens / Q000032:analysis; D001485:Basement Membrane; D002467:Cell Nucleus; D003176:Complement C3 / Q000032:analysis; D004247:DNA; D005260:Female; D007074:Immunoglobulin G / Q000032:analysis; D008297:Male; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000276:immunology; D010396:Penicillamine / Q000009:adverse effects*; D011507:Proteinuria / Q000139:chemically induced* / Q000276:immunology; D051381:Rats
D000418:Albumins; D000906:Antibodies; D000941:Antigens; D003176:Complement C3; D007074:Immunoglobulin G; D004247:DNA; D010396:Penicillamine
Proteinurie und nephrotisches Syndrom bei Penicillamin- Therapie. Reversibilität der immunpathologischen Befunde im Tierexperiment.